Abstract: The invention is directed to treatment or prevention of a disease characterized by deposition of Aß in the brain using anti-N3pGlu Aß antibodies. The diseases that can be treated or prevented include, e.g., Alzheimer's disease, Down's syndrome, and cerebral amyloid angiopathy. The invention, in some aspects, is related to doses and dosing regimens useful for such treatments. The invention is also related to, in some aspects, human subjects who are responsive to treatment or prevention of a disease characterized by deposition of Aß in the brain using anti-N3pGlu Aß antibodies. The invention is also related to human subject who have one or two alleles of APOE4.
| # | Name | Date |
|---|---|---|
| 1 | 202317047393-STATEMENT OF UNDERTAKING (FORM 3) [14-07-2023(online)].pdf | 2023-07-14 |
| 2 | 202317047393-Sequence Listing in txt [14-07-2023(online)].txt | 2023-07-14 |
| 3 | 202317047393-Sequence Listing in PDF [14-07-2023(online)].pdf | 2023-07-14 |
| 4 | 202317047393-REQUEST FOR EXAMINATION (FORM-18) [14-07-2023(online)].pdf | 2023-07-14 |
| 5 | 202317047393-POWER OF AUTHORITY [14-07-2023(online)].pdf | 2023-07-14 |
| 6 | 202317047393-FORM 18 [14-07-2023(online)].pdf | 2023-07-14 |
| 7 | 202317047393-FORM 1 [14-07-2023(online)].pdf | 2023-07-14 |
| 8 | 202317047393-DRAWINGS [14-07-2023(online)].pdf | 2023-07-14 |
| 9 | 202317047393-DECLARATION OF INVENTORSHIP (FORM 5) [14-07-2023(online)].pdf | 2023-07-14 |
| 10 | 202317047393-COMPLETE SPECIFICATION [14-07-2023(online)].pdf | 2023-07-14 |
| 11 | 202317047393-FORM-26 [17-07-2023(online)].pdf | 2023-07-17 |
| 12 | 202317047393-FORM 3 [19-07-2023(online)].pdf | 2023-07-19 |
| 13 | 202317047393-Proof of Right [28-09-2023(online)].pdf | 2023-09-28 |